Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients

NCT02624349 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Late Complication From Kidney Transplant
Complication of Transplanted Liver
Human Papillomavirus-Related Carcinoma

Interventions

DRUG: Quadravalent human papillomavirus vaccine

Sponsor

The Hospital for Sick Children

Collaborators

[object Object]
[object Object]